The prevalence of homologous recombination DNA damage repair (HR-DDR) deficiencies among all tumor lineages is not well characterized. Therapy directed toward homologous recombination DDR deficiency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback